SPOT-MAS 10 Multi-Cancer Early Detection

Advanced Early Detection · ctDNA Liquid Biopsy

Screen for 10 Cancers From One Blood Draw

SPOT-MAS 10 is an advanced ctDNA cancer marker test that screens for early signals of ten cancer types from a single, non-invasive blood draw. It reads circulating tumour DNA by methylation and fragment size, analysed with multi-AI models, and can predict the likely tumour of origin when a signal is found.

10 Cancer Types
ctDNA Liquid Biopsy
Single Blood Draw
Tumour-of-Origin Prediction
E-Consult Included

Sound Familiar?

Cancer runs in your family

Someone close to you has faced a cancer diagnosis, and you would rather understand your own picture sooner than later.

Most cancers have no routine test

Many common cancers still have no standard screening program, so they can go unseen until later. A broader net appeals to you.

You like to stay ahead

You take a proactive view of your health and want to catch potential signals at the earliest, most manageable stage.

You want something non-invasive

No scopes, no scans, no discomfort. The idea of meaningful screening from a simple blood draw is exactly what you are after.

You have reached your 40s

You have hit an age where broader screening makes sense, and you want a wider safety net alongside your usual checks.

You value peace of mind

Knowing where you stand, rather than wondering, is worth a great deal to you and the people who depend on you.

01

Signals Across 10 Cancers

A single screen looks for early tumour DNA signals across ten cancer types at once, including several that have no routine screening test.

Multi-Cancer Coverage

02

Likely Tumour of Origin

If a signal is found, the test predicts the most likely tissue of origin with high accuracy, giving your doctor a clear starting point.

Guided Follow-Up

03

A Clear Result

Your result comes back in a simple three-zone format of Negative, Intermediate, or Positive, so it is easy to understand and act on.

Easy to Read

04

From One Blood Draw

The whole screen runs from a single 10ml blood sample collected in a special kit. No scopes, no scans, no fasting required.

Non-Invasive

05

Advanced ctDNA Science

The test reads circulating tumour DNA by methylation and fragment size, interpreted through multi-AI machine learning models.

Methylation + Size

06

Guidance, Not Just a Result

Your included doctor e-consult helps you understand your result, and any positive signal is referred on to an oncologist for next steps.

E-Consult Included

What It Screens For

10 Cancer Types Detected

Screening by tumour DNA methylation and fragment size, analysed with multi-AI models.

ctDNA Liquid Biopsy

Breast

Screens for early tumour DNA signals from breast tissue.

Lung

Covers a cancer often found late, from a simple blood draw.

Colorectal

Signals from the colon and rectum, no scope required to screen.

Stomach

Gastric tumour DNA signals, one of several with no routine test.

Liver & Biliary Tract

Covers the liver, gallbladder, and bile duct region.

Ovary

Ovarian signals, a cancer that is difficult to catch early.

Pancreas

Pancreatic signals, another cancer with no standard screening.

Esophagus

Esophageal tumour DNA signals from the same blood sample.

Head & Neck

Covers cancers of the throat, mouth, and surrounding tissues.

Endometrium

Signals from the uterine lining, completing the ten-cancer panel.

How Your Screening Works

1

Book

Reserve your screening online or via WhatsApp and we coordinate your appointment.

2

Blood Draw

A single 10ml blood sample is collected into a special kit. No fasting needed.

3

Analysis

Your sample is analysed for ctDNA signals. Results are ready in about 14 working days.

4

Review

Your e-consult explains your result, and any positive signal is referred to an oncologist.

SPOT-MAS is a screening tool, not a diagnostic test. A positive or intermediate result requires follow-up with an oncologist for confirmation. A negative result lowers, but does not eliminate, the possibility of cancer, so continue with your routine age-appropriate screening. No fasting is required before your blood draw.

Why ReserveDaily

Easy Online Booking

Reserve your screening online or via WhatsApp. We handle the lab coordination and kit logistics for you.

CAP-Accredited Laboratory

Your sample is processed by a CAP-accredited partner laboratory, held to international standards for quality and accuracy.

Non-Invasive Single Draw

One simple blood draw, with the collection kit provided. No scopes, no scans, no downtime.

E-Consult and Referral Pathway

Every screening includes a doctor e-consult, and any positive result is guided on to an oncologist for next steps.

WhatsApp Support

Questions before you book? Chat with our team directly on WhatsApp and we will help you decide if this screening is right for you.

Results in About 14 Days

Your report is typically ready within about 14 working days from your blood draw, with your e-consult to follow.

Frequently Asked Questions

What is SPOT-MAS 10?

SPOT-MAS 10 is a non-invasive, ctDNA-based cancer marker test for multi-cancer early detection. From a single blood draw, it screens for early signals of ten cancer types by reading circulating tumour DNA through methylation and fragment size, interpreted with multi-AI models. It also predicts the most likely tumour of origin when a signal is detected.

Which cancers does it screen for?

It screens for signals across ten cancer types: breast, lung, colorectal, stomach, liver and biliary tract, ovary, pancreas, esophagus, head and neck, and endometrium. Several of these have no standard-of-care screening program, which is where a broad blood-based screen adds the most value.

Is this a diagnosis?

No. SPOT-MAS is a screening tool, not a diagnostic test. It looks for early tumour DNA signals in your blood. A positive or intermediate result requires follow-up with an oncologist for confirmation, and a negative result does not rule out cancer entirely.

How accurate is the test?

In validation studies, SPOT-MAS reported 78.1% sensitivity and 99.8% specificity, with a 99.9% negative predictive value. The high specificity means very few false alarms. The sensitivity means it detects many, but not all, cancers, which is why it is designed to complement rather than replace your routine age-appropriate screening.

Do I need to fast before the test?

No fasting is required. The test uses a single 10ml blood sample collected into a special kit, and you can eat and drink normally beforehand.

What does a positive result mean?

A positive result means tumour DNA signals were detected and the test has predicted a likely tissue of origin. It does not confirm cancer on its own. It is a prompt to follow up with an oncologist, who will use the tumour-of-origin prediction to guide the right confirmatory tests.

What does a negative result mean?

A negative result means no tumour DNA signals were detected at the time of testing. This lowers the likelihood of an active cancer among those screened, but it does not guarantee you are cancer-free. Continue with your usual age-appropriate screening such as mammograms or colonoscopy.

Does this replace my other cancer screenings?

No. SPOT-MAS 10 is designed to add to your existing screening, not replace it. It is a useful complement, especially for cancers that have no routine test. You can also explore our other health screening packages for a fuller picture of your health.

SPOT-MAS 10 is a cancer screening tool and not a diagnostic test. It screens for the presence of circulating tumour DNA and does not confirm or exclude cancer. A positive or intermediate result requires follow-up with an oncologist, and a negative result does not rule out cancer. This screening does not replace routine age-appropriate cancer screening or professional medical advice. Consult a qualified healthcare professional to interpret your results. Results may vary between individuals.